Pages that link to "Q38731224"
Jump to navigation
Jump to search
The following pages link to Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis. (Q38731224):
Displaying 9 items.
- Treatment Response and Outcome with Two Different Prednisolone Regimens in Autoimmune Hepatitis (Q48035309) (← links)
- Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis. (Q52641231) (← links)
- Comparative efficacy and tolerability of treatments for adult autoimmune hepatitis: A systematic review and network meta-analysis. (Q55428911) (← links)
- Hellenic Association for the Study of the Liver Clinical Practice Guidelines: Autoimmune hepatitis (Q60926015) (← links)
- [Autoimmune hepatitis-standard and second-line therapy] (Q88563888) (← links)
- Autoimmune Hepatitis in the Elderly: Diagnosis and Pharmacologic Management (Q89414799) (← links)
- Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group (Q89624081) (← links)
- Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the study of liver diseases (Q92166689) (← links)
- Immunosuppressive Treatment Regimens in Autoimmune Hepatitis: Systematic Reviews and Meta-Analyses Supporting AASLD Guidelines (Q96159169) (← links)